We hypothesize that LP03 attenuates BLM-induced pulmonary fibrosis through modulation of gut microbiota and elevation of palmitoylethanolamide (PEA), thereby suppressing the TGF-β1/Smad2/3-mediated EMT pathway. Here, SMAD2 is linked to pulmonary fibrosis.